Literature DB >> 24866707

Response to Early Intensive Behavioral Intervention for autism--an umbrella approach to issues critical to treatment individualization.

Leonardo Fava1, Kristin Strauss2.   

Abstract

Integrating knowledge across the disciplines of genetics, neurological, and behavioral science targets, so far, early identification of children with autism and thus early access to intervention. Cross-discipline collaboration might be substantially improve treatment efficacy via individualized treatment based on the child and family needs, consistency across treatment providers and careful planning of skill curricula, setting and techniques. This paper documents the current state of five main issues critical to treatment individualization where cross-discipline collaboration is warranted: (1) developmental timing, (2) treatment intensity, (3) heterogeneity in treatment response, (4) program breath and flexibility, and (5) formats of treatment provision.
Copyright © 2014 ISDN. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autism; Early Intensive Behavioral Intervention; Individualization; Outcome; Treatment

Mesh:

Year:  2014        PMID: 24866707     DOI: 10.1016/j.ijdevneu.2014.05.004

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  8 in total

1.  An Evaluation of the Impact of Supervision Intensity, Supervisor Qualifications, and Caseload on Outcomes in the Treatment of Autism Spectrum Disorder.

Authors:  Dennis R Dixon; Erik Linstead; Doreen Granpeesheh; Marlena N Novack; Ryan French; Elizabeth Stevens; Laura Stevens; Alva Powell
Journal:  Behav Anal Pract       Date:  2016-06-09

2.  A Program Evaluation of Home and Center-Based Treatment for Autism Spectrum Disorder.

Authors:  Dennis R Dixon; Claire O Burns; Doreen Granpeesheh; Roshan Amarasinghe; Alva Powell; Erik Linstead
Journal:  Behav Anal Pract       Date:  2016-10-25

3.  Demographic and Clinical Characteristics Associated with Engagement in Behavioral Health Treatment Among Children with Autism Spectrum Disorders.

Authors:  Lisa A Croen; Naomi Shankute; Meghan Davignon; Maria L Massolo; Cathleen Yoshida
Journal:  J Autism Dev Disord       Date:  2017-11

4.  An evaluation of the effects of intensity and duration on outcomes across treatment domains for children with autism spectrum disorder.

Authors:  E Linstead; D R Dixon; E Hong; C O Burns; R French; M N Novack; D Granpeesheh
Journal:  Transl Psychiatry       Date:  2017-09-19       Impact factor: 6.222

5.  Impact of the Early Start Denver Model on the cognitive level of children with autism spectrum disorder: study protocol for a randomised controlled trial using a two-stage Zelen design.

Authors:  Sandrine Touzet; Pauline Occelli; Carmen Schröder; Sabine Manificat; Ludovic Gicquel; Razvana Stanciu; Marie Schaer; Marie-Joelle Oreve; Mario Speranza; Angelique Denis; Amelie Zelmar; Bruno Falissard; Nicolas Georgieff; Stephane Bahrami; Marie-Maude Geoffray
Journal:  BMJ Open       Date:  2017-03-27       Impact factor: 2.692

6.  Screening, Diagnosis and Early Intervention in Autism Spectrum Disorders.

Authors:  Yurena Alonso-Esteban; Francisco Alcantud-Marín
Journal:  Children (Basel)       Date:  2022-01-25

Review 7.  A Scoping Literature Review of the Relation between Nutrition and ASD Symptoms in Children.

Authors:  Inge van der Wurff; Anke Oenema; Dennis de Ruijter; Claudia Vingerhoets; Thérèse van Amelsvoort; Bart Rutten; Sandra Mulkens; Sebastian Köhler; Annemie Schols; Renate de Groot
Journal:  Nutrients       Date:  2022-03-26       Impact factor: 5.717

8.  Study protocol of the multi-centre, randomised controlled trial of the Frankfurt Early Intervention Programme A-FFIP versus early intervention as usual for toddlers and preschool children with Autism Spectrum Disorder (A-FFIP study).

Authors:  Janina Kitzerow; Matthes Hackbusch; Katrin Jensen; Meinhard Kieser; Michele Noterdaeme; Ulrike Fröhlich; Regina Taurines; Julia Geißler; Nicole Wolff; Veit Roessner; Nico Bast; Karoline Teufel; Ziyon Kim; Christine M Freitag
Journal:  Trials       Date:  2020-02-24       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.